Fluoroquinolone-induced liver injury: Three new cases and a review of the literature

European Journal of Clinical Pharmacology

Volumn 68, Issue 5, 2012, Pages 525-532

  Licata, Anna ^a   Randazzo, Claudia ^a   Morreale, Ilaria ^a   Butera, Giuseppe ^a   D'Alessandro, Natale ^a   Craxì, Antonio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Acute liver failure; Fluoroquinolones; Hepatitis; Hepatotoxicity; Liver injury

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CIPROFLOXACIN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; LEVOFLOXACIN; STEROID;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CHOLESTATIC HEPATITIS; CREATININE BLOOD LEVEL; CYTOLYTIC HEPATITIS; DIARRHEA; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ECHOGRAPHY; FEVER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMODIALYSIS; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; JAUNDICE; LEUKOCYTOSIS; LIVER BIOPSY; LIVER NECROSIS; MALE; NAUSEA; PRIORITY JOURNAL; REVIEW; SPLENOMEGALY; STEATOSIS; TOXIC HEPATITIS;

ADULT; ANTI-BACTERIAL AGENTS; DRUG-INDUCED LIVER INJURY; FEMALE; FLUOROQUINOLONES; HUMANS; ITALY; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84864288097     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1201-6     Document Type: Review

References (60)

1. Desarro A, Desarro G (2001) Adverse reactions to fluoroquinolones. An overview on mechanistic aspects. Curr Med Chem 8:371-384
2. Lapi F, Tuccori M, Motola D et al (2010) Safety profile of the fluoroquinolones. Analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy. Drug Saf 33:789-799
3. Mehlhorn AJ, Brown DA (2007) Safety concerns with fluoroquinolones. Ann Pharmacother 41:1859-1866 (Pubitemid 350044349)
4. Gruppo di lavoro OsMed (2010) L'uso dei farmaci in Italia. Rapporto Nazionale. Roma: Il pensiero scientifico editore 2011
5. Polson JE (2007) Hepatotoxicity due to antibiotics. Clin Liver Dis 11:549-561 (Pubitemid 47302349)
6. Andrade RJ, Tulkens PM (2011) Hepatic safety of antibiotics used in primary care. J Antimicrob Chemother 66:1431-1446
7. George DK, Crawford DH (1996) Antibacterial-induced hepatotoxicity. Incidence, prevention and management. Drug Saf 15:79-85 (Pubitemid 26248760)
8. Andrade RJ, Lucena MI, Fernandez MC et al (2005) Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129:512-521 (Pubitemid 41096639)
9. Nori S, Nebesio C, Brashear R et al (2004) Moxifloxacinassociated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure. Arch Dermatol 140:1537-1538 (Pubitemid 39627455)
10. Grassmick BK, Lehr VT, Sundareson AS (1992) Fulminant hepatic failure possibly related to ciprofloxacin. Ann Pharmacother 26:636-639
11. Fuchs S, Simon Z, Brezis M (1994) Fatal hepatic failure associated with ciprofloxacin. Lancet 343:738-739 (Pubitemid 24087878)
12. Spahr L, Rubbia-Brandt L, Marinescu O et al (2001) Acute fatal hepatitis related to levofloxacin. J Hepatol 35:308-309 (Pubitemid 32803490)
13. Thiim M, Friedman LS (2003) Hepatotoxicity of antibiotics and antifungals. Clin Liver Dis 7:381-399 (Pubitemid 36807738)
14. Danan G, Benichou C (1993) Causality assessment of adverse reactions to drugs. I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46:1323-1330 (Pubitemid 23333873)
15. Naranjo CA, Busto U, Sellers EM et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239-245 (Pubitemid 12149145)
16. García-Cortés M, Lucena MI, Pachkoria K, for the Spanish Group for the Study of Drug-induced Liver Disease (grupo de Estudio para las Hepatopatias Asociadas a Medicamentos, Geham) et al (2008) Evaluation of Naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther 27:780-789 (Pubitemid 351490076)
17. Orman ES, Conjeevaram HS, Vuppalanchi R et al (2011) Clinical and histopathologic features of fluoroquinolone-induced liver injury. Clin Gastroenterol Hepatol 9:517-523
18. Alan C, Koçoǧlu H, Ersay AR et al (2011) Unexpected severe hepatotoxicity of ciprofloxacine: two case reports. Drug Chem Toxicol 34:189-191
19. Titos-Arcos JC, Hallal H, Robles M et al (2011) Acute cholestatic hepatitis associated with levofloxacin. Gastroenterol Hepatol 34:369-370
20. Figueira-Coelho J, Pereira O, Picado B et al (2010) Acute hepatitis associated with the use of levofloxacin. Clin Ther 32:1733-1737
21. Cholongitas E, Georgousaki C, Spyrou S et al (2009) Ciprofloxacin-induced acute cholestatic hepatitis. Ann Hepatol 8:400-401
22. Carrascosa MF, Lucena MI, Andrade RJ et al (2009) Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection. Clin Ther 31:1014-1019
23. García-Aparicio J, Herrero-Herrero JI (2010) Toxic hepatitis following sequential treatment with cotrimoxazol, levofloxacin, doxycycline and sertraline in a patient with a respiratory infection. Farm Hosp 34:152-154
24. Verma R, Dhamija R, Batts DH et al (2009) Moxifloxacin induced fatal hepatotoxicity in a 72-year-old man: a case report. Cases J 2:8063
25. Dichiara AJ, Atkinson M, Goodman Z et al (2008) Ciprofloxacin-induced acute cholestatic liver injury and associated renal failure. Case report and review. Minerva Gastroenterol Dietol 54:307-315
26. Bhagirath KM (2008) A case report of highly suspected ciprofloxacin-induced hepatotoxicity. Turk J Gastroenterol 19:204-206
27. Okan G, Yaylaci S, Peker O et al (2008) Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus. World J Gastroenterol 14:4697-4700
28. Coban S, Ceydilek B, Ekiz F et al (2005) Levofloxacin-induced acute fulminant hepatic failure in a patient with chronic hepatitis B infection. Ann Pharmacother 39:1737-1740 (Pubitemid 41393136)
29. Zimpfer A, Propst A, Mikuz G et al (2004) Ciprofloxacin-induced acute liver injury: case report and review of literature. Virchows Arch 444:87-89 (Pubitemid 38200096)
30. Goetz M, Galle PR, Schwarting A (2003) Non-fatal acute liver injury possibly related to high-dose ciprofloxacin. Eur J Clin Microbiol Infect Dis 22:294-296 (Pubitemid 36760452)
31. Schwalm JD, Lee CH (2003) Acute hepatitis associated with oral levofloxacin therapy in a hemodialysis patient. CMAJ 168:847-848 (Pubitemid 36433938)
32. Airey KJ, Koller E (2003) Acute hepatitis associated with levaquin in a patient with renal insufficiency taking amiodarone. CMAJ 14:169
33. Bataille L, Rahier J, Geubel A (2002) Delayed and prolonged cholestatic hepatitis with ductopenia after long-term ciprofloxacin therapy for Crohn's disease. J Hepatol 37:696-699 (Pubitemid 35305554)
34. Soto S, López-Rosés L, Avila S et al (2002) Moxifloxacin-induced acute liver injury. Am J Gastroenterol 97:1853-1854
35. Contreras MA, Luna R, Mulero J et al (2001) Severe ciprofloxacin-induced acute hepatitis. Eur J Clin Microbiol Infect Dis 20:434-435 (Pubitemid 32651771)
36. Karim A, Ahmed S, Rossoff LJ (2001) Possible levofloxacin-induced acute hepatocellular injury in a patient with chronic obstructive lung disease. Clin Infect Dis 33:2088-2090 (Pubitemid 33152410)
37. Nakamae H, Hino M, Yamane T (2000) A case of rhabdomyolysis due to levofloxacin. Clin Drug Invest 20:203-205
38. Björnsson E, Olsson R (2000) Norfloxacin-induced eosinophilic necrotizing granulomatous hepatitis. Am J Gastroenterol 95:3662-3663
39. Iannini PB (2007) The safety profile of moxifloxacin and other fluoroquinolones in special patient populations. Curr Med Res Opin 23:1403-1413 (Pubitemid 46998448)
40. O'Donnell JA, Gelone SP (2000) Fluoroquinolones. Infect Dis Clin North Am 14:489-513 (Pubitemid 30308108)
41. De Valle MB, Av Klinteberg V, Alem N et al (2006) Drug induced liver injury in a Swedish university hospital out-patient hepatology clinic. Aliment Pharmacol Ther 24:1187-1195 (Pubitemid 44427506)
42. Van Bambeke F, Tulkens PM (2009) Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes. Drug Saf 32:359-378
43. Chalasani N, Björnsson E (2010) Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology 138:2246-2259
44. Aithal GP, Day CP (2007) Nonsteroidal anti-inflammatory drug induced hepatotoxicity. Clin Liver Dis 11:563-575 (Pubitemid 47307394)
45. Larson AM (2007) Acetaminophen hepatotoxicity. Clin Liver Dis 11:525-548 (Pubitemid 47302345)
46. Elouni B, Ben Salem C, Zamy M (2010) Cytolytic hepatitis possibly related to levonorgestrel/ethinylestradiol oral contraceptive use: 2 case reports. Ann Pharmacother 44:2035-2037
47. Wolfson JS, Hooper DC (1991) Overview of fluoroquinolone safety. Am J Med 91:153-161
48. Liu HH (2010) Safety profile of the fluoroquinolones. Focus on levofloxacin. Drug Saf 33:353-369
49. Owens RC, Ambrose PG (2005) Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis 41 [Suppl 2]:S144-S157 (Pubitemid 40962485)
50. Jones SE, Smith RH (1997) Quinolones may induce hepatitis. BMJ 314:869
51. Hautekeete ML, Kockx MM, Naegels S et al (1995) Cholestatic hepatitis related to quinolones: a report of two cases. J Hepatol 23:759-760 (Pubitemid 26013287)
52. Blum A (1991) Ofloxacin-induced acute severe hepatitis. South Med J 84:1158
53. EMEA/CHMP (issued 24/07/08) European Medicines Agency recommends restricting the use of oral moxifloxacin-containing medicines. http://www.emea.europa.eu/pdfs/human/press/pr/38292708en.pdf
54. Lopez-Navidad A, Domingo P, Cadafalch J et al (1990) Norfloxacin-induced hepatotoxicity. J Hepatol 11:277-278
55. Davoren P, Mainstone K (1993) Norfloxacin-induced hepatitis. Med J Aust 159:423-426
56. Lucena MI, Andrade RJ, Sánchez-Martinez H et al (1998) Norfloxacin-induced cholestatic jaundice. Am J Gastroenterol 93:2309-2311
57. Romero-Gómez M, Suárez García E, Fernández MC (1999) Norfloxacin-induced acute cholestatic hepatitis in a patient with alcoholic liver cirrhosis. Am J Gastroenterol 94:2324-2325
58. Henann NE, Zambie MF (2001) Gatifloxacin-associated acute hepatitis. Pharmacotherapy 21:157-182
59. Ball P, Mandell L, Niki Y et al (1999) Comparative tolerability of the newer fluoroquinolone antibacterials. Drug Saf 21:407-421 (Pubitemid 29520901)
60. Bertino J Jr, Fish D (2000) The safety profile of the fluoroquinolones. Clin Ther 22:798-817 (Pubitemid 30625913)